Cargando…
Neuronal activity induces glucosylceramide that is secreted via exosomes for lysosomal degradation in glia
Recessive variants in GBA1 cause Gaucher disease, a prevalent form of lysosome storage disease. GBA1 encodes a lysosomal enzyme that hydrolyzes glucosylceramide (GlcCer) into glucose and ceramide. Its loss causes lysosomal dysfunction and increased levels of GlcCer. We generated a null allele of the...
Autores principales: | Wang, Liping, Lin, Guang, Zuo, Zhongyuan, Li, Yarong, Byeon, Seul Kee, Pandey, Akhilesh, Bellen, Hugo J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278864/ https://www.ncbi.nlm.nih.gov/pubmed/35857503 http://dx.doi.org/10.1126/sciadv.abn3326 |
Ejemplares similares
-
Exploring therapeutic strategies for infantile neuronal axonal dystrophy (INAD/PARK14)
por: Lin, Guang, et al.
Publicado: (2023) -
Ubiquilins Regulate Autophagic Flux through mTOR Signaling and Lysosomal Acidification
por: Şentürk, Mümine, et al.
Publicado: (2019) -
ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins
por: Villarroya-Beltri, Carolina, et al.
Publicado: (2016) -
The Glucosylceramide Synthase Inhibitor PDMP Causes Lysosomal Lipid Accumulation and mTOR Inactivation
por: Hartwig, Pia, et al.
Publicado: (2021) -
Lysosomal Functions in Glia Associated with Neurodegeneration
por: Kreher, Conlan, et al.
Publicado: (2021)